chrisvoncsefalvay/vaers-outcomes huggingface dataset:
First sign was inflammation of lymph node under right arm. Progressed to include headache, nausea, muscle aches, fever and hypersensitivity and pain on the right arm near the site of injection by evening and sustained for the following four days. On Saturday, 10/23/2010, the right arm broke out in large red blotches. Doctor's appointment made for Sunday at 11 a.m., resulting in prescription of Relafen and recommendation use ice on the affected arm and to consume two Benadryl at bedtime.   Current status is that hypersensitivity in the right arm persists, but the red blotches have begun to reduce.
Child broke out in hives 02/29/2006.  Did not call doctor until 03/02/2006.  Seen by doctor on 03/02/2006.
Mild soreness first day. Warm, slightly pink second day. Red slightly raised warm area the size of half dollar with a 3 inch pink ring around it for almost a week. Finally went away. Never had any reaction before and have been getting flu vaccinations for 6+ years.
Few hours later pt developed itchy, swollen rash around right eye, nose, around lips, posterior neck and then arms.  Pt reports skin irritation around the lips, but no lip/tongue swelling and no trouble breathing at anytime.   The patient has a history of eczema and hikes regularly.  He admits that the rash could also be related to plant exposure from a hike a few days prior to 10/30/2020 (date of flu vaccine and onset of rash).
Short-lived sharp chest pain across lung area, entire width of chest 12 hours after injection. Panic attack at 7 days with chest pains that varied in location and sensation. Insomnia began at about 10 days. Shortness of breath for hours at a time began around 12 days with Insomnia. Heavy anxiety since the 7 day mark, just don't feel normal, never felt this way in my life.
This spontaneous report as received from a medical assistant refers to unspecified number of patients of unknown age and unknown gender. The unspecified patients pertinent medical history was not reported. On an unknown date the, unspecified number of patients were vaccinated with GARDASIL (Lot # J007264 and expiry date: 02-MAR-2017) which was improperly stored. No product quality complaint was reported for GARDASIL. Reporter provided that there have been no reported adverse events following administration of the vaccinations. There has been no need for revaccination. This is one of the several reports from the same reporter. Additional information has been requested.
I received the vaccine and started having headaches the next day. It has now been 12 days and I am not better. I was forced to take the vaccine by university as a remote student. My doctor sent a medical exemption that they denied and didn't tell me why
p/vax pt presented w/T100.2; edema rt thigh; + limping; site of inj red; tx: keflex; thigh improved
Hives; itches; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of hives in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced hives (Verbatim: Hives) and pruritus (Verbatim: itches). The outcome of the hives and pruritus were not reported.   It was unknown if the reporter considered the hives and pruritus to be related to Shingles vaccine.     It was unknown if the company considered the hives and pruritus to be related to Shingles vaccine.   Additional Information: GSK receipt date: 21-JUL-2023 This case was reported by a patient via interactive digital media. The patient stated that he was glad that he got the vaccine however, since then was experiencing hives and itches. The patient was not sure if adverse event was related to the vaccine. The follow-up could not be possible as no contact details were available. This case is linked with US2023AMR101704, same reporter.
5 days after the injection i noticed  a 1 inch irregular red patch . It was itchy at times but not painful. It was about 4 inches below vaccine injection site. 2 days later I noticed that the  the red itchy patch had faded but expanded and was now in a circular pattern about 2 inches in diameter. The site was slightly raised, faded red in color, warm to the touch and tender but not painful.
Pt received MODERNA vaccine at age 16 at Occupational Group. The MODERNA vaccine is currently FDA approved for ages 18 and up.
Fatigue; Chills; This case was reported by a consumer via interactive digital media and described the occurrence of fatigue in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (Family History) (had shingles many years ago). Previously administered products included Shingles vaccine with an associated reaction of no adverse event (1st dose received on an unknown date).   In February 2022, the patient received the 2nd dose of Shingles vaccine. In February 2022, less than a week after receiving Shingles vaccine, the patient experienced fatigue and chills. On an unknown date, the outcome of the fatigue and chills were recovered/resolved.   It was unknown if the reporter considered the fatigue and chills to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient received dose of Shingles vaccine and experienced 24 hours of fatigue and chills but would go through it a thousand times to avoid the horrific case of shingles, the patient's mother had it many years before reporting. The patient stated that a day of being tired was nothing compared to shingles. The follow-up would not possible as no contact details were available.
This is a spontaneous report from a contactable consumer reporting for herself. A 65-year-old female patient of an unspecified ethnicity  received PREVNAR 13 , via an unspecified route of administration at the beginning of the 2016  at single dose for immunization.  The patient medical history was not reported. There were no concomitant medications. She never had any reactions with the vaccines. The patient stated that after half an hour or hour later of the vaccination, her face became completely flushed, her face was completely red and injection site become hard on an unspecified date with outcome of unknown. In Jan2017 was planned another pneumonia vaccine.
Given wrong 2nd dose to patient. Should have received Pfizer but was given Moderna even though it isn't approved for < 18 years of age.
Moderna, Dose Number: 3 / Pfizer, Dose Number: 1, 2, 4; Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Nurse).  A 35-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 11Nov2022 as dose 4 (booster), single (Lot number: gj3277) at the age of 35 years, in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 16Mar2021 as dose 1, single (Lot number: ER2613), in left arm and on 06Apr2021 as dose 2, single (Lot number: EW0158), in left arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 19Dec2021 as dose 3 (booster), single (Lot number: 077h21a), in left arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 2023, outcome "unknown" and all described as "Treatment of COVID-19"; INTERCHANGE OF VACCINE PRODUCTS (medically significant), outcome "unknown", described as "Moderna, Dose Number: 3 / Pfizer, Dose Number: 1, 2, 4". Therapeutic measures were taken as a result of vaccination failure, covid-19 which included Paxlovid which was given on 06Mar2023.; Sender's Comments: Based on available information, a lack of efficacy (VACCINATION FAILURE and COVID-19) under interchange of vaccine products with the suspect vaccine BNT162B2 in this patient cannot be completely excluded.
Vaccination provided to patient around 11:20AM, at around 4:15PM patient's spouse called to speak to pharmacist about patient complaining of pain to the injection site with a very sore arm, being unable to lift the arm of injection. Spouse requested this be reported. The spouse was advised to continue to have patient monitor his arm and call his PCP for further recommendations. She was advised to have patient seek emergency care if the pain is intolerable. RPH provided VIS form at informed patient about potential side effects after vaccination which included pain at the inject site that could potentially spread further down the arm, redness, soreness, fever, chills. RPH is currently awaiting patient's callback once pt and spouse can get in contact with pt's PCP.
pt recvd vax 24AUG93 & w/in 30 seconds pt c/o throat hurting became pale, diaphoretic, coughing holding throat w/hand; BP 60/40, P70; became lethargic; pt vomited;
p/vax flu like sx on 10/9/99;aches, sweats, high temp fever 101-102, cough, led to pneumonia;ER at hosp-7 days in hosp;02 IV; out of work;60 day follow-up dated 9/26/00 provided no additional data. Annual follow-up dated 9/26/00 provided no additional data.
Approximately 3 months after my booster vaccine of Moderna, I began to have severe vertigo that caused vomiting and nausea. I almost fell over and I could hardly walk. I did feel well enough a day later to drive myself to a hospital and went to the ER. This is where my pulse was low to 40 and my blood pressure was extremely elevated. I was then released to go back home and take prescribed medication. The medication did help a lot and the symptoms did go away. About a week ago I did have a slight version of the same symptoms, and was given another prescription from my primary care. I was referred to see an ENT and cardiologist sometime in April.  I am feeling much better as of now.
First vaccine shot on 3/9/2021, second on 3/30/2021. Symptoms appeared on 11/3/2021 when I noticed a substantial change in my vision in my left eye. I started on fluoxetine on 11/1, so initially believed it to be a side effect of that medication. After the issue persisted, I saw an ophthalmologist on 11/11/2021 who diagnosed me with multiple evanescent white dot syndrome. In researching, I read a report there could be a link to the Pfizer vaccine, so figured it best to report this. I am getting additional labs and have a follow-up on 11/23 to confirm the diagnosis. Typically, this disease resolves itself after a few weeks/months.
Flu like symptoms. Achy joints, cold chills and hot sweats, foggy head
Hard red swelling at injection site approximately the size of a half dollar, constant intense itching and warmth at the injection site. Above reaction lasted 72 hours. Mild soreness at the injection site lasted 48 hours I used ice packs to help control the swelling and itching Side effects returned on March 5, 2021 with slightly larger area of redness, but not quite as red (more pink), itching,  mild swelling
shingles outbreak; 2nd dose scheduled for today (11May2021), 1st dose 21 days ago; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (shingles outbreak) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose scheduled for today (11May2021), 1st dose 21 days ago) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Allergic to drug dulaglutide.).    On 11-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On an unknown date, the patient experienced HERPES ZOSTER (shingles outbreak) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose scheduled for today (11May2021), 1st dose 21 days ago). The patient was treated with VALACYCLOVIR HYDROCHLORIDE ongoing since an unknown date for Herpes zoster, at an unspecified dose and frequency and PREDNISONE ongoing since an unknown date for Herpes zoster, at an unspecified dose and frequency. At the time of the report, HERPES ZOSTER (shingles outbreak) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose scheduled for today (11May2021), 1st dose 21 days ago) outcome was unknown.            The information about concomitant products was declined
Initial report received from a Pharmacist on 15 Jan 2010: This patient, with an unknown medical history was vaccinated with 0.5 ml FLUVIRIN (Batch number 104045P1), intramuscularly, on an unspecified date. The FLUVIRIN vaccine was stored at a temperature which was as low as 34 degrees Fahrenheit and 35 degrees Fahrenheit. No adverse event was reported.
Patient complained of sore tongue and tingling and burning sensation over all skin surface. No rash however. Starting several days after vaccine administration
Pt. stated he was slightly dizzy after vaccinations at approximately 1:55 PM. Dizziness completely resolved per patient by 2:08 PM.
pt recv vax & devel redness & inflammation @ the site of vax;pt recovered;
Information has been received from a physician concerning a female patient who on an unknown date was vaccinated with a second dose of Gardasil. Subsequently, the patient experienced significant pain around the injection site which lasted for a week or longer after receiving the vaccine. Unspecified medical attention was sought. It was also reported that the same reaction occurred after the first dose of Gardasil. No product quality complaint was involved. Additional information has been requested.
redness and warmth at injection site; redness and warmth at injection site; This is a spontaneous report from a contactable consumer (patient). A 32-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN 5318), via an unspecified route of administration at the right arm on 25Jan2021 07:00 at single dose for COVID-19 immunization. Medical history included heartburn and mildly allergic to peanuts. Concomitant medication included fluoxetine hydrochloride (PROZAC), ethinylestradiol, ferrous fumarate, norethisterone acetate (LO LOESTRIN FE), ascorbic acid (VITAMIN C), curcuma longa rhizome (TURMERIC). The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19. The patient experienced redness and warmth at injection site on 26Jan2021 08:00 with outcome of not recovered. The patient did not receive any treatment for the events.  No follow-up attempts are possible. No further information is expected.
Felt vaccine being injected and shoved into my shoulder. Hours later my left part of chest started having contractions for 24 hours. Almost like twitching in deep part of muscle or in heart Then it transferred into my arm pit being very sensitive and swollen and very tender to touch for 2 days.
I woke up 10 days after having my first shot woth a sore throat congestion in my chest clogged ears a swollen lymph nodes in my left arm pit
vocal cord paralysis; second outbreak of shingles; outbreak of painful shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unspecified age. Information about the patient's concurrent condition, concomitant medication or medical history was not provided. On 25-MAY-2016 the patient was vaccinated with zoster vaccine live(ZOSTAVAX) (strength, dose, route, lot # and expiration date were not reported) at a pharmacy for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). In approximately August 2016 (reported as approximately two and one-half months after vaccination), the patient suffered debilitating injuries including an outbreak of painful shingles. Patient subsequently experienced a second outbreak of shingles and vocal cord paralysis (dates unknown) which had required extensive medical treatment and would require surgery. These injuries were caused by the zoster vaccine live(ZOSTAVAX) vaccine.  As a direct and proximate result of zoster vaccine live(ZOSTAVAX), patient's symptoms have resulted in physical injuries and limitations not present prior to using the product. Patient sustained severe and disfiguring personal injuries. Further, as a tragic consequence of zoster vaccine live(ZOSTAVAX). Patient suffered serious, progressive, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. The outcome of events was not recovered. The lawyer considered the events to be related to zoster vaccine live(ZOSTAVAX).   Upon internal review, two times outbreak of shingles and vocal cord paralysis were determined to be disable.
Rash on legs, followed by fever. Rash appears on arms, and part of face. Some rashes on torso. Fever for two days (8/14 & 8/15). Treated with Tylenol. Rash darken and appear to be clearing on the third day. Signs of the rash still present as of today.
I contracted Covid-19 in August and was eventually admitted to the CCU unit on 8/18/2021 at hospital.  Primary care director is Dr. I am still testing positive for Covid-19 and still have symptoms.
FEVER, MIGRAINE, ARM REDNESS AND SWELLING, ENLARGED LYMPH NODES UNDER LEFT ARM; TREATED WITH BENADRYL AND ADVIL; EVENTS STOPPED 1/14/2022.
Injection site sore; Intense headache; This is a spontaneous report from a contactable consumer (patient). A 28-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in arm left on 11Mar2021 15:30 (Lot Number: EN6204) (at the age of 28-years-old) as 1st dose, single dose for Covid-19 immunisation.  Medical history included allergies: latex, tree nuts, shellfish, environmental allergens. The patient did not receive other vaccines in four weeks. Concomitant medication(s) included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL); diphenhydramine hydrochloride (BENADRYL); colecalciferol (D3); lamotrigine (LAMICTAL); cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) and zinc, all taken for an unspecified indication, start and stop date were not reported.  The patient experienced injection site sore and intense headache on 12Mar2021. No treatment was received for the adverse events. The patient was not tested for COVID post vaccination. Outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
Believes she received the first Shingrix vaccine March 13, 2019 / Not sure if she received the second dose; This case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 13th March 2019).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The patient did not receive the 2nd dose of Shingrix as per the vaccination schedule, which led to incomplete course of vaccination. The patient was not sure if she received only one vaccine or if she received the second dose in the vaccine series as she was unable to verify with her pharmacy. It was unclear if this was an inappropriate schedule of vaccine, as the customer could not verify the details. The reporter did not consent to follow up.  Note: Possibly invalid case, but kept valid with worst case if the dose was not received since the patient was confused and called to report AE.
nausea; fever; chills; swollen/stiff/sore joints (esp. fingers); swollen/stiff/sore joints (esp. fingers); swollen/stiff/sore joints (esp. fingers); painful swelling in left armpit; painful swelling in left armpit; This is a spontaneous report from a contactable pharmacist. A 42-year-old female patient received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: solution for injection, Lot number: FD0168, Expiration date were not provided), via an unspecified route of administration in left arm on 08Apr2021 04:00 PM (Age at vaccination: 42-years) as dose 2, Single for covid-19 immunization. The patient was not pregnant at time of vaccination. The patient medical history included asthma. The patient had no known allergies. Patient concomitant medications included ZOLOFT (sertraline hydrochloride), vitamin B12, CLARITINE (loratadine) and other medications in Two weeks: PROZAC (Fluoxetine), all for unknown indication and start and stop date were unknown. Historical vaccine included bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: solution for injection, Lot number and Batch no/Expiration date were not provided) via an unspecified route of administration in left arm on 18Mar2021 14:30 PM (age at vaccination 42-years-old) as dose 1, single for COVID-19 immunization. On 09Apr2021 09:15 AM the patient experienced nausea, fever, chills, swollen/stiff/sore joints (esp. fingers) and painful swelling in left armpit. The patient did not receive any treatment. Prior to vaccination patient was not diagnosed with COVID-19. Since the vaccination patient has not been tested for COVID-19. The outcome of all the events was recovering except for chills which was unknown.  No follow-up attempts are needed. No further information is expected.
4/3/21 Lip swelling started last night, sensation of throat swelling. Diagnosed with angioedema
Chills, Body Aches, Runny Nose, Sore Throat, Cough, Headache, positive COVID-19 test
This is a spontaneous report from a contactable physician via a sales representative. An elderly female patient of an unspecified age received PREVNAR 13, lot number and expiration date were not reported, via an unspecified route of administration on an unspecified date at a single dose for immunization. Medical history included rheumatoid arthritis. The patient's concomitant medications were not reported. On an unspecified date in 2016/2017 the patient experienced bursitis in elbow/experienced bursitis-like reaction in elbow/arm. The outcome of the event was unknown. Information on the lot number has been requested.
Both of patients eyes turned "bloodshot" red. There were yellow residues in the corner of eyes. Patient also experienced some full body aches and chills. Patient took some Ibuprofen, 1/2 BENADRYL, Vitamin C.
Information has been received from a Licensed Vocation Nurse (LVN) referring to a 7 weeks old male patient who had no relevant medical history, concomitant medications or drug allergies. On 07-JUL-2016, the patient received his first dose of ROTATEQ (2 ml, oral, lot # L029615, expiration date 15-MAY-2017) which was exposed to a temperature excursion. There was no relevant laboratory data. After the vaccination, no adverse events had been reported thus far. This is one of several reports received from the same reporter. Additional information has been requested.
12/24/21 presents to ED for "ileostomy output increase". PMHx of "Cerebral palsy, spastic quadraparesis, nonverbal, w g-tube, VP shunt & ostomy, hx of SBO"